Estimates Revisions BioNTech SE Boerse Muenchen
Stocks
22UA
US09075V1026
Biotechnology & Medical Research
|
Market Closed -
Boerse Muenchen
02:27:44 22/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 100.00 EUR | +5.54% |
|
+18.73% | +16.54% |
| 21/08 | European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading | MT |
| 21/08 | BioNTech, neoantigens by proxy |  |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- BNTX Stock
- 22UA Stock
- Consensus BioNTech SE
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
